Solorank.ai
Login

Cached score snapshot

US.HUM · Humana

110分制 45.9/110；5D動能v2 1/50；排序分 46.9/160

Back to ranking Open volume snapshot
Ranking score 46.9/160
Main score 45.9/110
5D momentum v2 1/50
Rank #398
Setup grade F 19

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 19 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-23 08-05 09-17 10-08 10-28 $343.49$412.84$482.20 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.334 · anchors 120 +0.65% -0.78% / +3.55% 63.8% 2.5% Actual outcome pending · 0 / 3 bars observed
30D observation +10.57% +2.32% / +16.68% 81.3% 8.8% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 +1.05% -0.94% / +3.72% 61.3% 3.1% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-06-23 → 2026-10-28 · 120 archived points · 1 Improving turn signal · 4 Deteriorating signal · 1 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 46.9
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 45.9/110 (避免)
5D momentum v2 1/50 (弱)
Score with momentum v2 46.9/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 393.6035
ma50 389.1104
close 384.47
prevClose 396.62
avgVolume20 948872
volumeRatio 0.79
changePercent -3.06

Metrics snapshot

close 384.47
volume 746843
changePercent -3.06

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 45.9/110
Main rating 避免
5D momentum v2 1/50
Score with momentum v2 46.9/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.9/5 · 較差
Dimension score 2.9/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 287.1387
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 7.6/20 · 較差
Dimension score 7.6/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 2.4
obvPoints 1.6
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.HUM
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 6/15 · 較差
Dimension score 6/15
Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 17.2

trend

score 0.8

details

qqq

ma20 712.6675
ma50 709.8782
name QQQ
close 704.72
points 0.4

spy

ma20 764.672
ma50 759.1874
name SPY
close 754.05
points 0.4
source twelvedata+fred
atrPct 3.5678
atrPoints 2
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 0.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 5.9/10 · 較差
Dimension score 5.9/10
Dimension grade 較差

Sub-items

position

score 1.3

details

atrPct 3.5678
turnoverUsdM 287.1387
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.HUM
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 357.0358

strength_details

ma_score 2
atr_score 1
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.1
take_profit_price 403.8568
target_multiplier 1.6
technical_strength 1.33
take_profit_percent 5
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.1356
diversificationPoints 2

技術信號 — 17.5/30 · 較差
Dimension score 17.5/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 1.8
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 1.8
vcp_reason 波幅收縮(17.2%→8.8%)；跌縮量(近10日4日)；Ready=N；Confirm=N

vcp_metrics

up_days 5
vol_ref 1006940
down_days 4
vcp_ready false
above_ma50 false
avg_vol_10 864550
avg_vol_20 948590
avg_vol_30 1006940
range_pct_10 0.0875
range_pct_20 0.1261
range_pct_30 0.1724
up_expand_ok false
lookback_used 59
near_20d_high false
contraction_ok true
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.8586
dist_to_20d_high 0.0845
down_shrink_days 4
breakout_level_20d 419.97
vcp_breakout_confirm false
contraction_ratio_10_30 0.5077
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.4

情緒分析 — 4/10 · 較差
Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 2
sentimentScoreRaw 0.6

sentimentData

raw {"id":142158658,"url":"https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...","category":"company","datetime":1789463559,"headline":"Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"}, {"id":142029915,"url":"https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]","category":"company","datetime":1788986449,"headline":"Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"}, {"id":141400599,"url":"https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]","category":"company","datetime":1788446067,"headline":"Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"}, {"id":141363990,"url":"https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...","category":"company","datetime":1788271598,"headline":"Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"}, {"id":141363993,"url":"https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787934616,"headline":"Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"}, {"id":141363996,"url":"https://finnhub.io/api/news?id=9eebc30394e146a6bbd2335bcc2941657d67727c4c1d98358cc6753aac07f891","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (NYSE:HUM) is sponsoring 1,000 Home Health Aide scholarships in Indiana and launching a broad collaboration with HealthStream to address caregiver shortages. The effort targets recruitment, training and retention of home-based caregivers, with a focus on underserved and rural communities. The program aims to support quality and continuity of home-based care as demand for in home services grows. Explore other healthcare stocks that are investing in workforce capacity, digital tools...","category":"company","datetime":1787699878,"headline":"Humana (HUM) Backs 1,000 Indiana Home Health Aide Scholarships"}, {"id":141363997,"url":"https://finnhub.io/api/news?id=113b739abd66042c9c6f4a01976044dea0bba3744bc7821551df70bc43445128","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a mixed picture that leaves investors weighing how much of the story is already reflected in the price. Year to date, Humana is up 46.2%, which puts recent gains front and centre for anyone assessing what the current valuation implies. Recent moves such as the value based partnership with DaVita and the appointment of a new Chief Medical Officer may support confidence in Humana's care model and...","category":"company","datetime":1787692378,"headline":"Can Humana (HUM) Stay Cheap If Medicare Advantage Margins Tighten?"}, {"id":141282114,"url":"https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).","category":"company","datetime":1787171162,"headline":"Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"}
raw_source {"id":142198233,"url":"https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.","category":"company","datetime":1789579013,"headline":"The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"}, {"id":142195393,"url":"https://finnhub.io/api/news?id=3b6bdf092a40c927edad0623e8edc6e5b71ea42aeeb8a305c4b1d7ce904318a9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., September 16, 2026--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and soci","category":"company","datetime":1789560000,"headline":"Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide"}, {"id":142160447,"url":"https://finnhub.io/api/news?id=4b9006c710441c6abe75ec2c80a73863bb98fbc34d77513d5450c84b1e5fbe3b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"DUBLIN, Ohio, September 15, 2026--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients.","category":"company","datetime":1789475400,"headline":"Quantum Health Names Dr. Susan Mani as Chief Medical Officer"}, {"id":142160446,"url":"https://finnhub.io/api/news?id=d67ac2dbf48f6d0dd329d1ab5d26bad186d15e36a2775d4b1c565d6f5111cfbb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio","category":"company","datetime":1789470000,"headline":"CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions"}, {"id":142158658,"url":"https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...","category":"company","datetime":1789463559,"headline":"Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"}, {"id":142148504,"url":"https://finnhub.io/api/news?id=109a37c3b4773b9929db5c05c3b3c1772031edcc000e87fd9e98d6856be6a6c6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.","category":"company","datetime":1789438099,"headline":"CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences"}, {"id":142141425,"url":"https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.","category":"company","datetime":1789420257,"headline":"CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"}, {"id":142141467,"url":"https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.","category":"company","datetime":1789414884,"headline":"Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"}, {"id":142088659,"url":"https://finnhub.io/api/news?id=bdc2f3449be06089f2a7a0fff4946e8fcf53edb531611c3d7f202790ddc443c0","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will","category":"company","datetime":1789133712,"headline":"10 Health Care Stocks With Whale Alerts In Today’s Session"}, {"id":142064801,"url":"https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.","category":"company","datetime":1789069012,"headline":"Should You Buy Elevance Health Stock For The Margin It Lost?"}, {"id":142063328,"url":"https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.","category":"company","datetime":1789061100,"headline":"UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"}, {"id":142062099,"url":"https://finnhub.io/api/news?id=5ef3409d6896f45882c982d485a19acdb3f58328a0fe0fbafc647d8ddf483972","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., September 10, 2026--A new peer-reviewed study from Humana Healthcare Research published in Health Affairs Scholar found that Medicare Advantage beneficiaries who used an integrated specialty pharmacy, which coordinates pharmacy services with a beneficiary’s health plan, experienced faster access to specialty medications and lower out-of-pocket pharmacy costs compared with beneficiaries using non-integrated specialty pharmacies. The research suggests that greater coordination bet","category":"company","datetime":1789048800,"headline":"New Study Links Integrated Specialty Pharmacy Care to Faster Access and Lower Costs"}, {"id":142060930,"url":"https://finnhub.io/api/news?id=2e74443f51fae12373b55f78e2aa434fd344482bd09547fc850da95b2f997f90","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.","category":"company","datetime":1789045980,"headline":"BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?"}, {"id":142029915,"url":"https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]","category":"company","datetime":1788986449,"headline":"Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"}, {"id":142028659,"url":"https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.","category":"company","datetime":1788982210,"headline":"Why Is UNH Stock Trading At A Premium With The Slowest Growth?"}, {"id":142025948,"url":"https://finnhub.io/api/news?id=40dfd9205ae43e624ebad1b59d50330d3017274c720b1d7abe70d6b8ef8c5fe4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.","category":"company","datetime":1788967800,"headline":"Can UnitedHealth's AI Strategy Strengthen Optum Insight's Growth?"}, {"id":142029916,"url":"https://finnhub.io/api/news?id=3966d13a5e361af4bd335e93fb8462237491ffa516fecce2986dba7d99b8387f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.","category":"company","datetime":1788965754,"headline":"Is Humana Stock Outperforming the Dow?"}, {"id":142025949,"url":"https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.","category":"company","datetime":1788964814,"headline":"UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"}, {"id":142024396,"url":"https://finnhub.io/api/news?id=fee7ff8411d4d6ec06d6d4910d7f911dd35d3fd361ea815c362df264666f9d36","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"HUM","summary":"Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.","category":"company","datetime":1788957301,"headline":"Stay updated with the S&P500 stocks that are on the move in today's pre-market session."}, {"id":141546908,"url":"https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.","category":"company","datetime":1788642735,"headline":"Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."}, {"id":141446662,"url":"https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.","category":"company","datetime":1788537840,"headline":"UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"}, {"id":141423004,"url":"https://finnhub.io/api/news?id=b47380288cfd261087fd1c7cf10b6f8585c62315443d5115620975ccc52ecc91","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.","category":"company","datetime":1788522610,"headline":"1 High-Flying Stock for Long-Term Investors and 2 Facing Headwinds"}, {"id":141423002,"url":"https://finnhub.io/api/news?id=5a680d055ddeb06d8e5ed20a8ec2f72d7a90a006a3aa38bc3fb209ea607b65ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney disease patients and agreed to a US$15 million settlement related to a prior data breach. Investors have been reacting to this mix of partnership news and legal resolution with a share price that is still up 58.64% year to date, despite a 30 day share price return of down 20.32%. The 3 year total shareholder return of 90.54% points to momentum...","category":"company","datetime":1788520425,"headline":"DaVita (DVA) Has Investors Asking A Fresh Question"}, {"id":141403928,"url":"https://finnhub.io/api/news?id=de3b755458a0692786e98c8730379abffa2f396e858720998b049556eefd1eec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana's non-renewal letters are already in the mail, and the deadline to act is closer than most affected members realize. Missing it by even one day changes what coverage options remain available and how much they cost.","category":"company","datetime":1788463703,"headline":"If Your Advantage Plan Ends December 31 and You Do Nothing, You Wake Up January 1 in Original Medicare With No Drug Coverage and No Medigap."}, {"id":141402794,"url":"https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.","category":"company","datetime":1788456945,"headline":"UnitedHealth Stock Recovered Before Its Margins Did"}, {"id":141400357,"url":"https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.","category":"company","datetime":1788446735,"headline":"CVS Stock Has Left Its Peers Behind. Or Has It?"}, {"id":141400598,"url":"https://finnhub.io/api/news?id=3a6679a4fcbe4b0468c5eb51b8e05f0b6aa44ae84a4b8c4a728e14059920ae68","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the clinics, who absorbs the loss, and what federal prosecutors are targeting next.","category":"company","datetime":1788446287,"headline":"For 4 Years, The Villages’ Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million."}, {"id":141400599,"url":"https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]","category":"company","datetime":1788446067,"headline":"Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"}, {"id":141398394,"url":"https://finnhub.io/api/news?id=5ecbb193cb85190f3f48ea058a6967f06b7f0314381e2841cd1b73bdd1c3bf22","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., September 03, 2026--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition","category":"company","datetime":1788440400,"headline":"Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition"}, {"id":141398395,"url":"https://finnhub.io/api/news?id=52197c23d741cca5892b2746c42c80631fda597e5439d0029571d1b451bb190a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"By endorsing Mark Cuban‘s proposals to make prescription drug pricing more transparent, Bill Ackman shifted the conversation from healthcare policy to something investors care about just as much: whether the traditional pharmacy benefit manager (PBM) model is facing a growing...","category":"company","datetime":1788438664,"headline":"Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose"}, {"id":141379619,"url":"https://finnhub.io/api/news?id=955bd6154f46d896e37490a441a69875797708f3521c372fac6045a27e93d5e9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Thyme Care, the nationally recognized oncology company, today announced a new Series E financing round of over $125M. Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.","category":"company","datetime":1788364800,"headline":"Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem"}, {"id":141379150,"url":"https://finnhub.io/api/news?id=fac6b53077cb17d7af20e819aacca07cf62593653b986be157b110f4bed8e7fd","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1788356125,"headline":"10 Health Care Stocks Whale Activity In Today’s Session"}, {"id":141376490,"url":"https://finnhub.io/api/news?id=7089e5e97cc78f2f8e46f615a87ce7a52143f01f13c4c4c92cd02ceb8756bbeb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., September 02, 2026--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026.","category":"company","datetime":1788348600,"headline":"Humana Board Declares Payment of Quarterly Dividend to Stockholders"}, {"id":141379621,"url":"https://finnhub.io/api/news?id=a6d938412017df82b4c3588f20f001f57b3cf997f8e58993d6676030daa79f8a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Daniel Chojnowski, JHHP’s current CFO, will provide stability so that the Baltimore-area insurer can recruit full-time for its next chief executive, the company said.","category":"company","datetime":1788346743,"headline":"Johns Hopkins Health Plans taps interim CEO as it searches for successor"}, {"id":141363990,"url":"https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...","category":"company","datetime":1788271598,"headline":"Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"}, {"id":141363991,"url":"https://finnhub.io/api/news?id=7c73358c9d2b5f1658b408c9e638de39c0052960157b94807434371d0c767764","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., September 01, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program.","category":"company","datetime":1788267600,"headline":"Humana Foundation Names 2026 Scholarship Recipients"}, {"id":141369187,"url":"https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51","image":"https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.","category":"company","datetime":1788267096,"headline":"Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"}, {"id":141371368,"url":"https://finnhub.io/api/news?id=44123b131d75bfb6f1388867c0d31be1514fc4941a8c48213c2ed05025802002","image":"","source":"Benzinga","related":"HUM","summary":"https://www.sec.gov/ix?doc=/Archives/edgar/data/0000049071/000004907126000052/hum-20260901.htm","category":"company","datetime":1788248223,"headline":"Humana Reiterates FY26 Adjusted EPS Outlook Of At Least $9"}, {"id":141361168,"url":"https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.","category":"company","datetime":1788204328,"headline":"UNH Stock Gets Cheaper Only If The Margins Come Back"}, {"id":141363992,"url":"https://finnhub.io/api/news?id=ffde99a5e0fe49fb4a8d5dbbe5de9c2ce50d65cce5f98ee9d00646e9a0845b91","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.","category":"company","datetime":1788107422,"headline":"Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October."}, {"id":141348696,"url":"https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.","category":"company","datetime":1787943961,"headline":"Is CVS Stock Set for a Rebound?"}, {"id":141364000,"url":"https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.","category":"company","datetime":1787935140,"headline":"CVRx Secures Devoted Health Coverage for Barostim Therapy"}, {"id":141363993,"url":"https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787934616,"headline":"Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"}, {"id":141348699,"url":"https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.","category":"company","datetime":1787876791,"headline":"Can a $68 Billion Payout Save UNH Stock?"}, {"id":141364004,"url":"https://finnhub.io/api/news?id=3440e44b4a6d31c25e39dba536afd6b4c6da7895a1529c2e3e756b4c15e80838","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.","category":"company","datetime":1787841427,"headline":"2 S&P 500 Stocks with Competitive Advantages and 1 That Underwhelm"}, {"id":141363994,"url":"https://finnhub.io/api/news?id=5f73510a717dcfbd979a82e39bf4b27dda3921dadcc42cab65408c26a5979b77","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The Central Florida provider manufactured fake diagnosis codes for its Medicare Advantage patients from 2020 to 2024, the DOJ said. Humana bought The Villages Health last year.","category":"company","datetime":1787830200,"headline":"Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare"}, {"id":141364005,"url":"https://finnhub.io/api/news?id=d81e396c75c2fbce692e32683a385ad0c1f96d53d2e46cf61922465d010a4b57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"SAN FRANCISCO & NEW YORK, August 27, 2026--Zip Forward makes its NYC debut, featuring leaders from Shopify, Visa, Databricks, and Invesco, along with Pro Football Hall of Famer Michael Strahan","category":"company","datetime":1787828400,"headline":"Zip Forward 2026: \"Flow State\" to Bring Together Over 1000 Finance and Procurement Leaders in New York City"}, {"id":141363995,"url":"https://finnhub.io/api/news?id=bd4b4ac88b5f2ce54a4c0c3023a1ba33eb8c243e1631a0a5c1e3a702257d8f8c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.","category":"company","datetime":1787764980,"headline":"Here's Why Investors Should Retain Humana Stock for Now"}, {"id":141364006,"url":"https://finnhub.io/api/news?id=6be4f08a791f095f712c42c90f05cad55e89b9f1cfa1625c583cd96f579e82a3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department.","category":"company","datetime":1787739133,"headline":"Monogram Health to pay $2.4M to settle Medicare Advantage upcoding allegations"}, {"id":141363996,"url":"https://finnhub.io/api/news?id=9eebc30394e146a6bbd2335bcc2941657d67727c4c1d98358cc6753aac07f891","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (NYSE:HUM) is sponsoring 1,000 Home Health Aide scholarships in Indiana and launching a broad collaboration with HealthStream to address caregiver shortages. The effort targets recruitment, training and retention of home-based caregivers, with a focus on underserved and rural communities. The program aims to support quality and continuity of home-based care as demand for in home services grows. Explore other healthcare stocks that are investing in workforce capacity, digital tools...","category":"company","datetime":1787699878,"headline":"Humana (HUM) Backs 1,000 Indiana Home Health Aide Scholarships"}, {"id":141363997,"url":"https://finnhub.io/api/news?id=113b739abd66042c9c6f4a01976044dea0bba3744bc7821551df70bc43445128","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a mixed picture that leaves investors weighing how much of the story is already reflected in the price. Year to date, Humana is up 46.2%, which puts recent gains front and centre for anyone assessing what the current valuation implies. Recent moves such as the value based partnership with DaVita and the appointment of a new Chief Medical Officer may support confidence in Humana's care model and...","category":"company","datetime":1787692378,"headline":"Can Humana (HUM) Stay Cheap If Medicare Advantage Margins Tighten?"}, {"id":141363998,"url":"https://finnhub.io/api/news?id=a22c7adae1e24ce140ae7494bf0247e1d208d4f69aeec0569d564f567b9c6401","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"DaVita (NYSE:DVA) has expanded its partnership with Humana (NYSE:HUM) through a new value-based care agreement covering more than 10,000 Medicare Advantage members living with chronic kidney disease. The programme, which launched on July 1, targets patients with stages 3B through 5 chronic kidney disease (CKD).","category":"company","datetime":1787659638,"headline":"DaVita and Humana Expand Kidney Care Partnership to More Than 10,000 Patients"}, {"id":141316362,"url":"https://finnhub.io/api/news?id=e23cd2404230271f73651a2c9358e605f9ebc8477fd99d9a15a5da602ede6c71","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208603114/image_2208603114.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"Diamond Hill Small-Mid Cap Strategy increased 9.73% (net of fees) compared to a 20.26% increase for the Russell 2500 Index. Read more here.","category":"company","datetime":1787651220,"headline":"Diamond Hill Small-Mid Cap Strategy Q2 2026 Portfolio Review"}, {"id":141363156,"url":"https://finnhub.io/api/news?id=9e6cd2d3660275e88096f75e80364a5cf4917009be7ae999492f30bc308868a6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.","category":"company","datetime":1787650560,"headline":"Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina"}, {"id":141318607,"url":"https://finnhub.io/api/news?id=a4c2baebf2d01b5799e24966e573c7430250e8ea208b793e054ffcb1486afeaf","image":"","source":"Benzinga","related":"HUM","summary":"Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As","category":"company","datetime":1787638363,"headline":"DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5"}, {"id":141364007,"url":"https://finnhub.io/api/news?id=daa4b329210965095cc3c03058557d010b0951d5addcd4308432e740df9ea1f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Every September, Medicare plans mail a document most enrollees skim past without realizing the page after the premium notice can quietly rewrite their entire healthcare budget for the coming year.","category":"company","datetime":1787605377,"headline":"Your Medicare Plan’s 2027 Changes Have to Reach You by September 30. The Numbers That Cost You Are Easy to Miss."}, {"id":141348706,"url":"https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.","category":"company","datetime":1787594668,"headline":"UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"}, {"id":141278437,"url":"https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.","category":"company","datetime":1787349486,"headline":"Is The Pullback In UNH Stock A Glitch Or A Warning?"}, {"id":141278439,"url":"https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.","category":"company","datetime":1787333520,"headline":"Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"}, {"id":141278449,"url":"https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.","category":"company","datetime":1787244420,"headline":"Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"}, {"id":141282105,"url":"https://finnhub.io/api/news?id=28519a00412e241ddc0b2316680245d23eb0d09c3525c47e7239048511f5e594","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., August 20, 2026--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will r","category":"company","datetime":1787227200,"headline":"Humana Names Dr. Shantanu Nundy as Chief Medical Officer"}, {"id":141278441,"url":"https://finnhub.io/api/news?id=8bbcb50138decae38ed578ff993643f02aee591f40024bde3c1e02dc3746f399","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Dr. Shantanu Nundy is joining the Kentucky-based insurer from health navigation firm Accolade. He’s had a varied career — advising the FDA on AI, teaching, working for the World Bank, practicing medicine and more.","category":"company","datetime":1787223843,"headline":"Humana taps physician executive as new chief medical officer"}, {"id":141282114,"url":"https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).","category":"company","datetime":1787171162,"headline":"Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"}, {"id":141258963,"url":"https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.","category":"company","datetime":1787159760,"headline":"UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"}, {"id":141279621,"url":"https://finnhub.io/api/news?id=ef88b4db26a94236c2ae97c48e671e7ae0ad4893bd5dd000ee89f002e99fba0c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Costco stock reclaimed a key technical level on Tuesday as the warehouse club climbed amid news of a partnership to offer Medicare Advantage plans to members. Costco Wholesale will offer co-branded plans in partnership with nonprofit health insurer Scan Group. Scan, based in Long Beach, Calif., has about 560,000 Medicare Advantage members in Southern California, Arizona, Nevada, New Mexico and Texas, according to the Wall Street Journal.","category":"company","datetime":1787080732,"headline":"Costco Stock Sets Up Amid Medicare Advantage News"}, {"id":141275095,"url":"https://finnhub.io/api/news?id=e2b4a279455a0776b0ea8407e9fd95a06396fdacb37c0bf034bbb91f2ce65e6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Joel Greenblatt built Gotham Asset Management on concentrated value bets, so his latest 13F filing caught analysts off guard with moves that look less like a stock-picker's conviction and more like someone quietly bracing for impact.","category":"company","datetime":1787069545,"headline":"Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift"}, {"id":141244705,"url":"https://finnhub.io/api/news?id=be80c4cb30856d289d827b5c8223d809a45988346066920470f0734de8ace71d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345765699/image_1345765699.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.","category":"company","datetime":1787028060,"headline":"U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership"}, {"id":141239729,"url":"https://finnhub.io/api/news?id=ccd2ea8851c0b4b01e6bcf4847b75690ef0993697f38657d9476c66c127a9022","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1786973716,"headline":"4 Health Care Stocks With Whale Alerts In Today’s Session"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 2
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 68
discarded_article_count 60
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.9 5/110 58% 2.9
資金流 7.6 20/110 38% 7.6
市場環境 6 15/110 40% 6
催化劑 2 20/110 10% 2
風險管理 5.9 10/110 59% 5.9
技術信號 17.5 30/110 58.33% 17.5
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 1/50
ret_5d -0.0389
max_score 50
max_total 50
raw_total 1
vcp_bonus 0
vol_ratio 0.7873
ret_points 0
vol_points 0
range_ratio 1.0765
volat_points 0
day_range_pct 0.0354
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.3

details

atrPct 3.5678
turnoverUsdM 287.1387
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.HUM
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 357.0358

strength_details

ma_score 2
atr_score 1
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.1
take_profit_price 403.8568
target_multiplier 1.6
technical_strength 1.33
take_profit_percent 5
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.1356
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.9/5分
資金流分析總分: 7.6/20分
市場環境分析總分: 6/15分
催化劑分析: 2/20分
風險管理總分: 5.9/10分
技術信號分析總分: 17.5/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 78.57
atr
atr 13.7171
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.57
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -51.31
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1838
kdj
d 50.66
j 5.18
k 35.5
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 52.45
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 4
trend 弱勢
value 12938057
recentSlope -93214.3
previousSlope 482160
rsi
value 45.83
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 419.4418
position SAR喺價上
distancePct 9.1
previousTrend 下降
ma50
value 389.1104
macd
macd 3.9534
trend 中性偏多
signal 4.6981
histogram -0.7447
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 393.1919
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 空升
ratio 0.79
score 2
avgVolume 948872
currentVolume 746843
derived
ma20 393.6035
ma50 389.1104
prevClose 396.62
avgVolume10 833274
avgVolume20 948872
changePercent -3.06
avgVolumeForScore 948872
ma_cross
ma20 393.6035
ma50 389.1104
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 393.48
prevMa50 389.3134
spreadPct 1.15
isVolumeBreakout false
bollinger
lower 374.2541
upper 412.9529
position 中間
rsi_short
value 25.62
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.79

Raw calculation JSON

 
{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.567794626368767,
        "turnoverUsdM": 287.13872821,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 357.0358,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.1,
      "take_profit_price": 403.8568,
      "target_multiplier": 1.6,
      "technical_strength": 1.33,
      "take_profit_percent": 5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.135589252737534,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 46.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 45.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 393.6035,
    "ma50": 389.1104,
    "close": 384.47,
    "prevClose": 396.62,
    "avgVolume20": 948872,
    "volumeRatio": 0.79,
    "changePercent": -3.06
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.0388730299175124,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.7873190735723548,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.0764570129604905,
      "volat_points": 0,
      "day_range_pct": 0.03537334512445702,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 46.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 7.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 38,
        "contribution": 7.6
      },
      {
        "raw": 6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 40,
        "contribution": 6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 17.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58.33,
        "contribution": 17.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 45.9,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 7.6/20分",
      "市場環境分析總分: 6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 17.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 7.6,
      "市場環境": 6,
      "情緒分析": 4,
      "技術信號": 17.5,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 287.13872821,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 17.2
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 712.66749535,
                "ma50": 709.8781982999998,
                "name": "QQQ",
                "close": 704.71997,
                "points": 0.4
              },
              "spy": {
                "ma20": 764.6719933500001,
                "ma50": 759.18739938,
                "name": "SPY",
                "close": 754.049988,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.567794626368767,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142158658,
                "url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
                "category": "company",
                "datetime": 1789463559,
                "headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
              },
              {
                "id": 142029915,
                "url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
                "category": "company",
                "datetime": 1788986449,
                "headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
              },
              {
                "id": 141400599,
                "url": "https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]",
                "category": "company",
                "datetime": 1788446067,
                "headline": "Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"
              },
              {
                "id": 141363990,
                "url": "https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...",
                "category": "company",
                "datetime": 1788271598,
                "headline": "Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"
              },
              {
                "id": 141363993,
                "url": "https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934616,
                "headline": "Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"
              },
              {
                "id": 141363996,
                "url": "https://finnhub.io/api/news?id=9eebc30394e146a6bbd2335bcc2941657d67727c4c1d98358cc6753aac07f891",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) is sponsoring 1,000 Home Health Aide scholarships in Indiana and launching a broad collaboration with HealthStream to address caregiver shortages. The effort targets recruitment, training and retention of home-based caregivers, with a focus on underserved and rural communities. The program aims to support quality and continuity of home-based care as demand for in home services grows. Explore other healthcare stocks that are investing in workforce capacity, digital tools...",
                "category": "company",
                "datetime": 1787699878,
                "headline": "Humana (HUM) Backs 1,000 Indiana Home Health Aide Scholarships"
              },
              {
                "id": 141363997,
                "url": "https://finnhub.io/api/news?id=113b739abd66042c9c6f4a01976044dea0bba3744bc7821551df70bc43445128",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a mixed picture that leaves investors weighing how much of the story is already reflected in the price. Year to date, Humana is up 46.2%, which puts recent gains front and centre for anyone assessing what the current valuation implies. Recent moves such as the value based partnership with DaVita and the appointment of a new Chief Medical Officer may support confidence in Humana's care model and...",
                "category": "company",
                "datetime": 1787692378,
                "headline": "Can Humana (HUM) Stay Cheap If Medicare Advantage Margins Tighten?"
              },
              {
                "id": 141282114,
                "url": "https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).",
                "category": "company",
                "datetime": 1787171162,
                "headline": "Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"
              }
            ],
            "raw_source": [
              {
                "id": 142198233,
                "url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
                "category": "company",
                "datetime": 1789579013,
                "headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
              },
              {
                "id": 142195393,
                "url": "https://finnhub.io/api/news?id=3b6bdf092a40c927edad0623e8edc6e5b71ea42aeeb8a305c4b1d7ce904318a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 16, 2026--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and soci",
                "category": "company",
                "datetime": 1789560000,
                "headline": "Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide"
              },
              {
                "id": 142160447,
                "url": "https://finnhub.io/api/news?id=4b9006c710441c6abe75ec2c80a73863bb98fbc34d77513d5450c84b1e5fbe3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DUBLIN, Ohio, September 15, 2026--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients.",
                "category": "company",
                "datetime": 1789475400,
                "headline": "Quantum Health Names Dr. Susan Mani as Chief Medical Officer"
              },
              {
                "id": 142160446,
                "url": "https://finnhub.io/api/news?id=d67ac2dbf48f6d0dd329d1ab5d26bad186d15e36a2775d4b1c565d6f5111cfbb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio",
                "category": "company",
                "datetime": 1789470000,
                "headline": "CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions"
              },
              {
                "id": 142158658,
                "url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
                "category": "company",
                "datetime": 1789463559,
                "headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
              },
              {
                "id": 142148504,
                "url": "https://finnhub.io/api/news?id=109a37c3b4773b9929db5c05c3b3c1772031edcc000e87fd9e98d6856be6a6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.",
                "category": "company",
                "datetime": 1789438099,
                "headline": "CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences"
              },
              {
                "id": 142141425,
                "url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
                "category": "company",
                "datetime": 1789420257,
                "headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
              },
              {
                "id": 142141467,
                "url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
                "category": "company",
                "datetime": 1789414884,
                "headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
              },
              {
                "id": 142088659,
                "url": "https://finnhub.io/api/news?id=bdc2f3449be06089f2a7a0fff4946e8fcf53edb531611c3d7f202790ddc443c0",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1789133712,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 142064801,
                "url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
                "category": "company",
                "datetime": 1789069012,
                "headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
              },
              {
                "id": 142063328,
                "url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
                "category": "company",
                "datetime": 1789061100,
                "headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
              },
              {
                "id": 142062099,
                "url": "https://finnhub.io/api/news?id=5ef3409d6896f45882c982d485a19acdb3f58328a0fe0fbafc647d8ddf483972",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 10, 2026--A new peer-reviewed study from Humana Healthcare Research published in Health Affairs Scholar found that Medicare Advantage beneficiaries who used an integrated specialty pharmacy, which coordinates pharmacy services with a beneficiary’s health plan, experienced faster access to specialty medications and lower out-of-pocket pharmacy costs compared with beneficiaries using non-integrated specialty pharmacies. The research suggests that greater coordination bet",
                "category": "company",
                "datetime": 1789048800,
                "headline": "New Study Links Integrated Specialty Pharmacy Care to Faster Access and Lower Costs"
              },
              {
                "id": 142060930,
                "url": "https://finnhub.io/api/news?id=2e74443f51fae12373b55f78e2aa434fd344482bd09547fc850da95b2f997f90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.",
                "category": "company",
                "datetime": 1789045980,
                "headline": "BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?"
              },
              {
                "id": 142029915,
                "url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
                "category": "company",
                "datetime": 1788986449,
                "headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
              },
              {
                "id": 142028659,
                "url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
                "category": "company",
                "datetime": 1788982210,
                "headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
              },
              {
                "id": 142025948,
                "url": "https://finnhub.io/api/news?id=40dfd9205ae43e624ebad1b59d50330d3017274c720b1d7abe70d6b8ef8c5fe4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.",
                "category": "company",
                "datetime": 1788967800,
                "headline": "Can UnitedHealth's AI Strategy Strengthen Optum Insight's Growth?"
              },
              {
                "id": 142029916,
                "url": "https://finnhub.io/api/news?id=3966d13a5e361af4bd335e93fb8462237491ffa516fecce2986dba7d99b8387f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.",
                "category": "company",
                "datetime": 1788965754,
                "headline": "Is Humana Stock Outperforming the Dow?"
              },
              {
                "id": 142025949,
                "url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
                "category": "company",
                "datetime": 1788964814,
                "headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
              },
              {
                "id": 142024396,
                "url": "https://finnhub.io/api/news?id=fee7ff8411d4d6ec06d6d4910d7f911dd35d3fd361ea815c362df264666f9d36",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1788957301,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
              },
              {
                "id": 141546908,
                "url": "https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.",
                "category": "company",
                "datetime": 1788642735,
                "headline": "Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."
              },
              {
                "id": 141446662,
                "url": "https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.",
                "category": "company",
                "datetime": 1788537840,
                "headline": "UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"
              },
              {
                "id": 141423004,
                "url": "https://finnhub.io/api/news?id=b47380288cfd261087fd1c7cf10b6f8585c62315443d5115620975ccc52ecc91",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.",
                "category": "company",
                "datetime": 1788522610,
                "headline": "1 High-Flying Stock for Long-Term Investors and 2 Facing Headwinds"
              },
              {
                "id": 141423002,
                "url": "https://finnhub.io/api/news?id=5a680d055ddeb06d8e5ed20a8ec2f72d7a90a006a3aa38bc3fb209ea607b65ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney disease patients and agreed to a US$15 million settlement related to a prior data breach. Investors have been reacting to this mix of partnership news and legal resolution with a share price that is still up 58.64% year to date, despite a 30 day share price return of down 20.32%. The 3 year total shareholder return of 90.54% points to momentum...",
                "category": "company",
                "datetime": 1788520425,
                "headline": "DaVita (DVA) Has Investors Asking A Fresh Question"
              },
              {
                "id": 141403928,
                "url": "https://finnhub.io/api/news?id=de3b755458a0692786e98c8730379abffa2f396e858720998b049556eefd1eec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana's non-renewal letters are already in the mail, and the deadline to act is closer than most affected members realize. Missing it by even one day changes what coverage options remain available and how much they cost.",
                "category": "company",
                "datetime": 1788463703,
                "headline": "If Your Advantage Plan Ends December 31 and You Do Nothing, You Wake Up January 1 in Original Medicare With No Drug Coverage and No Medigap."
              },
              {
                "id": 141402794,
                "url": "https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.",
                "category": "company",
                "datetime": 1788456945,
                "headline": "UnitedHealth Stock Recovered Before Its Margins Did"
              },
              {
                "id": 141400357,
                "url": "https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.",
                "category": "company",
                "datetime": 1788446735,
                "headline": "CVS Stock Has Left Its Peers Behind. Or Has It?"
              },
              {
                "id": 141400598,
                "url": "https://finnhub.io/api/news?id=3a6679a4fcbe4b0468c5eb51b8e05f0b6aa44ae84a4b8c4a728e14059920ae68",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the clinics, who absorbs the loss, and what federal prosecutors are targeting next.",
                "category": "company",
                "datetime": 1788446287,
                "headline": "For 4 Years, The Villages’ Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million."
              },
              {
                "id": 141400599,
                "url": "https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]",
                "category": "company",
                "datetime": 1788446067,
                "headline": "Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"
              },
              {
                "id": 141398394,
                "url": "https://finnhub.io/api/news?id=5ecbb193cb85190f3f48ea058a6967f06b7f0314381e2841cd1b73bdd1c3bf22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 03, 2026--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition",
                "category": "company",
                "datetime": 1788440400,
                "headline": "Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition"
              },
              {
                "id": 141398395,
                "url": "https://finnhub.io/api/news?id=52197c23d741cca5892b2746c42c80631fda597e5439d0029571d1b451bb190a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "By endorsing Mark Cuban‘s proposals to make prescription drug pricing more transparent, Bill Ackman shifted the conversation from healthcare policy to something investors care about just as much: whether the traditional pharmacy benefit manager (PBM) model is facing a growing...",
                "category": "company",
                "datetime": 1788438664,
                "headline": "Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose"
              },
              {
                "id": 141379619,
                "url": "https://finnhub.io/api/news?id=955bd6154f46d896e37490a441a69875797708f3521c372fac6045a27e93d5e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Thyme Care, the nationally recognized oncology company, today announced a new Series E financing round of over $125M. Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.",
                "category": "company",
                "datetime": 1788364800,
                "headline": "Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem"
              },
              {
                "id": 141379150,
                "url": "https://finnhub.io/api/news?id=fac6b53077cb17d7af20e819aacca07cf62593653b986be157b110f4bed8e7fd",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1788356125,
                "headline": "10 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141376490,
                "url": "https://finnhub.io/api/news?id=7089e5e97cc78f2f8e46f615a87ce7a52143f01f13c4c4c92cd02ceb8756bbeb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 02, 2026--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026.",
                "category": "company",
                "datetime": 1788348600,
                "headline": "Humana Board Declares Payment of Quarterly Dividend to Stockholders"
              },
              {
                "id": 141379621,
                "url": "https://finnhub.io/api/news?id=a6d938412017df82b4c3588f20f001f57b3cf997f8e58993d6676030daa79f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Daniel Chojnowski, JHHP’s current CFO, will provide stability so that the Baltimore-area insurer can recruit full-time for its next chief executive, the company said.",
                "category": "company",
                "datetime": 1788346743,
                "headline": "Johns Hopkins Health Plans taps interim CEO as it searches for successor"
              },
              {
                "id": 141363990,
                "url": "https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...",
                "category": "company",
                "datetime": 1788271598,
                "headline": "Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"
              },
              {
                "id": 141363991,
                "url": "https://finnhub.io/api/news?id=7c73358c9d2b5f1658b408c9e638de39c0052960157b94807434371d0c767764",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 01, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program.",
                "category": "company",
                "datetime": 1788267600,
                "headline": "Humana Foundation Names 2026 Scholarship Recipients"
              },
              {
                "id": 141369187,
                "url": "https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.",
                "category": "company",
                "datetime": 1788267096,
                "headline": "Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"
              },
              {
                "id": 141371368,
                "url": "https://finnhub.io/api/news?id=44123b131d75bfb6f1388867c0d31be1514fc4941a8c48213c2ed05025802002",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "https://www.sec.gov/ix?doc=/Archives/edgar/data/0000049071/000004907126000052/hum-20260901.htm",
                "category": "company",
                "datetime": 1788248223,
                "headline": "Humana Reiterates FY26 Adjusted EPS Outlook Of At Least $9"
              },
              {
                "id": 141361168,
                "url": "https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.",
                "category": "company",
                "datetime": 1788204328,
                "headline": "UNH Stock Gets Cheaper Only If The Margins Come Back"
              },
              {
                "id": 141363992,
                "url": "https://finnhub.io/api/news?id=ffde99a5e0fe49fb4a8d5dbbe5de9c2ce50d65cce5f98ee9d00646e9a0845b91",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.",
                "category": "company",
                "datetime": 1788107422,
                "headline": "Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October."
              },
              {
                "id": 141348696,
                "url": "https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.",
                "category": "company",
                "datetime": 1787943961,
                "headline": "Is CVS Stock Set for a Rebound?"
              },
              {
                "id": 141364000,
                "url": "https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.",
                "category": "company",
                "datetime": 1787935140,
                "headline": "CVRx Secures Devoted Health Coverage for Barostim Therapy"
              },
              {
                "id": 141363993,
                "url": "https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934616,
                "headline": "Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"
              },
              {
                "id": 141348699,
                "url": "https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.",
                "category": "company",
                "datetime": 1787876791,
                "headline": "Can a $68 Billion Payout Save UNH Stock?"
              },
              {
                "id": 141364004,
                "url": "https://finnhub.io/api/news?id=3440e44b4a6d31c25e39dba536afd6b4c6da7895a1529c2e3e756b4c15e80838",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
                "category": "company",
                "datetime": 1787841427,
                "headline": "2 S&P 500 Stocks with Competitive Advantages and 1 That Underwhelm"
              },
              {
                "id": 141363994,
                "url": "https://finnhub.io/api/news?id=5f73510a717dcfbd979a82e39bf4b27dda3921dadcc42cab65408c26a5979b77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The Central Florida provider manufactured fake diagnosis codes for its Medicare Advantage patients from 2020 to 2024, the DOJ said. Humana bought The Villages Health last year.",
                "category": "company",
                "datetime": 1787830200,
                "headline": "Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare"
              },
              {
                "id": 141364005,
                "url": "https://finnhub.io/api/news?id=d81e396c75c2fbce692e32683a385ad0c1f96d53d2e46cf61922465d010a4b57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "SAN FRANCISCO & NEW YORK, August 27, 2026--Zip Forward makes its NYC debut, featuring leaders from Shopify, Visa, Databricks, and Invesco, along with Pro Football Hall of Famer Michael Strahan",
                "category": "company",
                "datetime": 1787828400,
                "headline": "Zip Forward 2026: \"Flow State\" to Bring Together Over 1000 Finance and Procurement Leaders in New York City"
              },
              {
                "id": 141363995,
                "url": "https://finnhub.io/api/news?id=bd4b4ac88b5f2ce54a4c0c3023a1ba33eb8c243e1631a0a5c1e3a702257d8f8c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.",
                "category": "company",
                "datetime": 1787764980,
                "headline": "Here's Why Investors Should Retain Humana Stock for Now"
              },
              {
                "id": 141364006,
                "url": "https://finnhub.io/api/news?id=6be4f08a791f095f712c42c90f05cad55e89b9f1cfa1625c583cd96f579e82a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department.",
                "category": "company",
                "datetime": 1787739133,
                "headline": "Monogram Health to pay $2.4M to settle Medicare Advantage upcoding allegations"
              },
              {
                "id": 141363996,
                "url": "https://finnhub.io/api/news?id=9eebc30394e146a6bbd2335bcc2941657d67727c4c1d98358cc6753aac07f891",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) is sponsoring 1,000 Home Health Aide scholarships in Indiana and launching a broad collaboration with HealthStream to address caregiver shortages. The effort targets recruitment, training and retention of home-based caregivers, with a focus on underserved and rural communities. The program aims to support quality and continuity of home-based care as demand for in home services grows. Explore other healthcare stocks that are investing in workforce capacity, digital tools...",
                "category": "company",
                "datetime": 1787699878,
                "headline": "Humana (HUM) Backs 1,000 Indiana Home Health Aide Scholarships"
              },
              {
                "id": 141363997,
                "url": "https://finnhub.io/api/news?id=113b739abd66042c9c6f4a01976044dea0bba3744bc7821551df70bc43445128",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a mixed picture that leaves investors weighing how much of the story is already reflected in the price. Year to date, Humana is up 46.2%, which puts recent gains front and centre for anyone assessing what the current valuation implies. Recent moves such as the value based partnership with DaVita and the appointment of a new Chief Medical Officer may support confidence in Humana's care model and...",
                "category": "company",
                "datetime": 1787692378,
                "headline": "Can Humana (HUM) Stay Cheap If Medicare Advantage Margins Tighten?"
              },
              {
                "id": 141363998,
                "url": "https://finnhub.io/api/news?id=a22c7adae1e24ce140ae7494bf0247e1d208d4f69aeec0569d564f567b9c6401",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DaVita (NYSE:DVA) has expanded its partnership with Humana (NYSE:HUM) through a new value-based care agreement covering more than 10,000 Medicare Advantage members living with chronic kidney disease. The programme, which launched on July 1, targets patients with stages 3B through 5 chronic kidney disease (CKD).",
                "category": "company",
                "datetime": 1787659638,
                "headline": "DaVita and Humana Expand Kidney Care Partnership to More Than 10,000 Patients"
              },
              {
                "id": 141316362,
                "url": "https://finnhub.io/api/news?id=e23cd2404230271f73651a2c9358e605f9ebc8477fd99d9a15a5da602ede6c71",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208603114/image_2208603114.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Diamond Hill Small-Mid Cap Strategy increased 9.73% (net of fees) compared to a 20.26% increase for the Russell 2500 Index. Read more here.",
                "category": "company",
                "datetime": 1787651220,
                "headline": "Diamond Hill Small-Mid Cap Strategy Q2 2026 Portfolio Review"
              },
              {
                "id": 141363156,
                "url": "https://finnhub.io/api/news?id=9e6cd2d3660275e88096f75e80364a5cf4917009be7ae999492f30bc308868a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.",
                "category": "company",
                "datetime": 1787650560,
                "headline": "Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina"
              },
              {
                "id": 141318607,
                "url": "https://finnhub.io/api/news?id=a4c2baebf2d01b5799e24966e573c7430250e8ea208b793e054ffcb1486afeaf",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Launched July 1, this partnership builds on the organizations&#39; long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As",
                "category": "company",
                "datetime": 1787638363,
                "headline": "DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5"
              },
              {
                "id": 141364007,
                "url": "https://finnhub.io/api/news?id=daa4b329210965095cc3c03058557d010b0951d5addcd4308432e740df9ea1f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Every September, Medicare plans mail a document most enrollees skim past without realizing the page after the premium notice can quietly rewrite their entire healthcare budget for the coming year.",
                "category": "company",
                "datetime": 1787605377,
                "headline": "Your Medicare Plan’s 2027 Changes Have to Reach You by September 30. The Numbers That Cost You Are Easy to Miss."
              },
              {
                "id": 141348706,
                "url": "https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.",
                "category": "company",
                "datetime": 1787594668,
                "headline": "UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"
              },
              {
                "id": 141278437,
                "url": "https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.",
                "category": "company",
                "datetime": 1787349486,
                "headline": "Is The Pullback In UNH Stock A Glitch Or A Warning?"
              },
              {
                "id": 141278439,
                "url": "https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.",
                "category": "company",
                "datetime": 1787333520,
                "headline": "Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"
              },
              {
                "id": 141278449,
                "url": "https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.",
                "category": "company",
                "datetime": 1787244420,
                "headline": "Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"
              },
              {
                "id": 141282105,
                "url": "https://finnhub.io/api/news?id=28519a00412e241ddc0b2316680245d23eb0d09c3525c47e7239048511f5e594",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., August 20, 2026--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will r",
                "category": "company",
                "datetime": 1787227200,
                "headline": "Humana Names Dr. Shantanu Nundy as Chief Medical Officer"
              },
              {
                "id": 141278441,
                "url": "https://finnhub.io/api/news?id=8bbcb50138decae38ed578ff993643f02aee591f40024bde3c1e02dc3746f399",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Dr. Shantanu Nundy is joining the Kentucky-based insurer from health navigation firm Accolade. He’s had a varied career — advising the FDA on AI, teaching, working for the World Bank, practicing medicine and more.",
                "category": "company",
                "datetime": 1787223843,
                "headline": "Humana taps physician executive as new chief medical officer"
              },
              {
                "id": 141282114,
                "url": "https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).",
                "category": "company",
                "datetime": 1787171162,
                "headline": "Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"
              },
              {
                "id": 141258963,
                "url": "https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.",
                "category": "company",
                "datetime": 1787159760,
                "headline": "UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"
              },
              {
                "id": 141279621,
                "url": "https://finnhub.io/api/news?id=ef88b4db26a94236c2ae97c48e671e7ae0ad4893bd5dd000ee89f002e99fba0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Costco stock reclaimed a key technical level on Tuesday as the warehouse club climbed amid news of a partnership to offer Medicare Advantage plans to members.  Costco Wholesale will offer co-branded plans in partnership with nonprofit health insurer Scan Group.  Scan, based in Long Beach, Calif., has about 560,000 Medicare Advantage members in Southern California, Arizona, Nevada, New Mexico and Texas, according to the Wall Street Journal.",
                "category": "company",
                "datetime": 1787080732,
                "headline": "Costco Stock Sets Up Amid Medicare Advantage News"
              },
              {
                "id": 141275095,
                "url": "https://finnhub.io/api/news?id=e2b4a279455a0776b0ea8407e9fd95a06396fdacb37c0bf034bbb91f2ce65e6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Joel Greenblatt built Gotham Asset Management on concentrated value bets, so his latest 13F filing caught analysts off guard with moves that look less like a stock-picker's conviction and more like someone quietly bracing for impact.",
                "category": "company",
                "datetime": 1787069545,
                "headline": "Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift"
              },
              {
                "id": 141244705,
                "url": "https://finnhub.io/api/news?id=be80c4cb30856d289d827b5c8223d809a45988346066920470f0734de8ace71d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345765699/image_1345765699.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.",
                "category": "company",
                "datetime": 1787028060,
                "headline": "U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership"
              },
              {
                "id": 141239729,
                "url": "https://finnhub.io/api/news?id=ccd2ea8851c0b4b01e6bcf4847b75690ef0993697f38657d9476c66c127a9022",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1786973716,
                "headline": "4 Health Care Stocks With Whale Alerts In Today’s Session"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 68,
            "discarded_article_count": 60
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.5,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.8,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.8,
            "vcp_reason": "波幅收縮(17.2%→8.8%)；跌縮量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1006940,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 864550,
              "avg_vol_20": 948590,
              "avg_vol_30": 1006940,
              "range_pct_10": 0.08752305771581657,
              "range_pct_20": 0.12606965432933656,
              "range_pct_30": 0.172393164616225,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.85859137585159,
              "dist_to_20d_high": 0.08452984737005023,
              "down_shrink_days": 4,
              "breakout_level_20d": 419.97,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5076944779722388
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.567794626368767,
              "turnoverUsdM": 287.13872821,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 357.0358,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.1,
            "take_profit_price": 403.8568,
            "target_multiplier": 1.6,
            "technical_strength": 1.33,
            "take_profit_percent": 5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.135589252737534,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 13.7171,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.57
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -51.31
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1838
    },
    "kdj": {
      "d": 50.66,
      "j": 5.18,
      "k": 35.5,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 52.45
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 12938057,
      "recentSlope": -93214.3,
      "previousSlope": 482160
    },
    "rsi": 45.83,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 419.4418,
      "position": "SAR喺價上",
      "distancePct": 9.1,
      "previousTrend": "下降"
    },
    "ma50": 389.1104,
    "macd": {
      "macd": 3.953436803787838,
      "trend": "中性偏多",
      "signal": 4.698139308368296,
      "histogram": -0.7447025045804576
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 393.1919,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.79,
      "score": 2,
      "avgVolume": 948872,
      "currentVolume": 746843
    },
    "derived": {
      "ma20": 393.6035,
      "ma50": 389.1104,
      "prevClose": 396.62,
      "avgVolume10": 833274,
      "avgVolume20": 948872,
      "changePercent": -3.06,
      "avgVolumeForScore": 948872
    },
    "ma_cross": {
      "ma20": 393.6035,
      "ma50": 389.1104,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 393.48,
      "prevMa50": 389.3134,
      "spreadPct": 1.15,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 374.2541,
      "upper": 412.9529,
      "position": "中間"
    },
    "rsi_short": 25.62,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.79
    }
  }
}

Raw metrics JSON

 
{
  "close": 384.47,
  "volume": 746843,
  "changePercent": -3.06
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.